Scientific Programme

Preloader Close

Please click the button below to view the scientific programme.

Hall C - Sala Napoleonica

	Hall C Sala Napoleonica
09:45-11:45	Pre-Conference Workshop 1 Older therapies for depression: practical guidance on indications and use - MAOIs, Lithium, Thyroid Hormone, Tricyclics, Tryptophan & Classic Combinations Allan Young (King's College London, UK), Philipp Ritter (University Hospital Carl Gustav Carus, Germany), Anthony Cleare (King's College London, UK), Eric Ruhe (Radboud University, Netherlands)
11:45-12:45	BREAK
12:45-14:45	Pre-Conference Workshop 2 Psychedelic therapy, what it is & how to do it Catherine Bird (King's College London, UK), Carolina Maggio (King's College London, UK), Liam Nadav Modlin (King's College London, UK) and James Rucker (King's College London, UK)
14:45-15:15	BREAK
15:15-15:30	Conference Opening Ceremony Anthony Cleare, King's College London, UK, ISAD President In Memoriam Prof. Eugene Paykel (1934-2023), ISAD Founder Fellow Allan Young, King's College London, UK, ISAD Past President
15:30-16:30	Presidential Opening Plenary Session Chair: Anthony Cleare, King's College London, UK Imaging and immunogenic features of affective (and non affective) psychosis Paolo Brambilla, University of Milan, Italy The finger of blame, depression and the brain Roland Zahn, King's College London, UK
16:30-18:00	Plenary Symposium 1 IGSLI Faculty Symposium: Quo Vadis LithiumTherapy? Chair: Janusz Rybakowski, Poznan University of Medical Sciences, Poland
	Genomic and neurobiological studies can elucidate the mode of action of lithium Martin Alda, Dalhousie University, Canada
	Lithium in the treatment of depression and suicide prevention Michael Bauer, Technical University of Dresden, Germany
	Adverse side effects of lithium: are they manageable? Ursula Werneke, Umeå University, Sweden
	For broader use of lithium: Correcting the anomalous association between lithium data and lithium use Janusz Rybakowski, Poznan University of Medical Sciences, Poland
18:00-18:15	Commentary: Patient and Public Involvement and Engagement Chair: Allan Young, King's College London, UK Patient perspectives on Lithium Marylou Selo, Patient Advocate, USA
18:15-19:30	Welcome Reception

Hall A - Aula Magna
Hall B - Aula 111

Hall A Aula Magna
08:55-09:00	Welcome back
09:00-10:30	Symposium 2 Treatment-resistant depression: Best practice and beyond Chair: Anthony Cleare, King's College London, UK
	Latest evidence on pharmacological augmentation for treatment-resistant depression: Does the Lithium versus Quetiapine (LQD) Study change best practice? Anthony Cleare, King's College London, UK
	The genetics of treatment-resistant depression: Results and new opportunities from biobanks and electronic health records Chiara Fabbri, University of Bologna, Italy
	Ketamine and esketamine for unipolar and bipolar depression Philipp Ritter, University Hospital Carl Gustav Carus Dresden, Germany
	The role of probiotic supplementation in Major Depressive Disorder and TRD Viktoriya Nikolova, King's College London, UK
10:30-11:15	Coffee Break & Poster Session A P-001 to P-030
11:15-12:00	Plenary Session 1 The Rational for Subtyping Depression in Research and Clinical Settings Martin Preisig, Lausanne University Hospital Center, Switzerland
12:00-13:00	Industry Session 1
13:00-14:00	Lunch Break and Exhibition
14:00-15:30	Symposium 4 Defining developmental trajectories of anxiety and depression throughout the lifespan: Risk factors and targets for prevention and treatment programs Chair: Paolo Brambilla, University of Milan, Italy
	The vulnerability stress model and longitudinal brain structure: Interaction of early and current environmental stress in affective disorders Tilo Kircher, University of Marburg, Germany
	Course prediction of depression and anxiety disorders in the NESDA project Brenda Penninx, Amsterdam UMC, The Netherlands
	Longitudinal neonatal brain development and environmental correlates of infant outcomes following preterm birth Chiara Nosarti, King's College London, UK
	Internalizing symptoms trajectories from childhood to early adulthood, through adolescence, in clinical and general population samples: Results from the REMIND project Maria Nobile, Scientific Institute IRCCS 'E. Medea', Italy
15:30-17:00	Short Oral Presentations Session 1 Chair: Anthony Cleare, King's College London, UK
15:30 - 15:45	O-01 Repetitive Transcranial Magnetic Stimulation: standard vs accelerated protocol’s efficacy on depressive core symptoms Valentina Fazio, Vita-Salute San Raffaele University, Italy
15:45 - 16:00	O-02 Do psychometrics matter? The effects of advanced psychometrics on antidepressant randomised trial outcomes Frank Doyle, RCSI University of Medicine and Health Sciences, Ireland
16:00 - 16:15	O-03 REDUCE (REviewing long term antiDepressant use by Careful monitoring in Everyday practice): randomised controlled trial Tony Kendrick, University of Southampton, UK
16:15 - 16:30	O-04 (Early Career Award Winner) Could low-dose lithium be a viable neuroprotective supplement? Rebecca Strawbridge, King's College London, UK
16:30 - 16:45	O-05 (Early Career Award Winner) Is there a biological link between bipolar disorder and frontotemporal dementia? A neuroimaging perspective Giuseppe Del Vecchio, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy
16:45 - 17:00	O-06 (Patient Advocate Award Winner) Hormones and hypersexuality: Challenges facing women with bipolar Clare Dolman, King's College London, UK
17:00-17:45	Coffee Break & Poster Session B P-031 to P-060

Hall B Aula 111
08:55-09:00	Welcome back
09:00-10:30	Symposium 3 Precision Medicine for Bipolar disorder: From Basic Science over Biomarkers to Clinical Practice Chair: Maurizio Ferrari, Synlab Italia SRL, Italy
	Emotional bias: A Core dimension of mood states. New findings on its mechanism Chantal Henry, GHU Paris, France
	The role of inflammation in the diagnosis pathogenesis and treatment of bipolar disorder Anne Cecile Petit, GHU Paris, France
	Innovative blood test to differentiate MDD from bipolar depression in patients Dinah Weissmann, ALCEDIAG, France
	EDIT-B test the new frontier of diagnostics in psychiatry Maurizio Ferrari, Synlab Italia SRL, Italy
10:30-11:15	Coffee Break & Poster Session A
11:15-12:00	Plenary Session 1 The Rational for Subtyping Depression in Research and Clinical Settings Martin Preisig, Lausanne University Hospital Center, Switzerland
12:00-13:00	Industry Session 1
13:00-14:00	Lunch Break, Exhibition
14:00-15:30	Symposium 5 Identifying novel neurocognitive targets for treating affective disorders Chair: Roland Zahn, IoPPN / King's College London, UK
	Neurocognitive intervention targets for depression Roland Zahn, IoPPN, King's College London, UK
	Neurocognitive intervention targets for trauma-related disorders Mirus Jindrova, Central Institute of Mental Health, Germany
	Neurocognitive intervention targets for mood instability and self-harm Martina Di Simplicio, Imperial College London, UK
	Neurocognitive intervention targets for bipolar disorders Rebecca Strawbridge, IoPPN, King's College London, UK
15:30-17:00	Short Oral Presentations Session 2
15:30 - 15:45	O-07 Ketamine alters anterior cingulate dynamics in depressed individuals Laith Alexander, King's College London, UK
15:45 - 16:00	O-08 The role of Implicit and Explicit Self-Esteem in the relationship between Childhood Trauma and Adult Depression and Anxiety Anouk Gathier, Amsterdam UMC, Netherlands
16:00 - 16:15	O-09 Diagnostic accuracy of deep learning using speech samples in depression: a systematic review and meta-analysis Lidan Liu, King's College London, UK
16:15 - 16:30	O-10 Subjective cognitive impairment in bipolar disorder: predictors of discrepancy with objective cognition and association with functioning. Michail Kalfas, King's College London, UK
16:30 - 16:45	O-11 Healthcare utilisation and associated economic burden in treatment-resistant depression – a UK population-based cohort study Sofia Pappa,Imperial College, UK
16:45 - 17:00	O-12 Natural Language Response Formats for Assessing Depression Zhuojun Gu, Lund University, Sweden
17:00-17:45	Coffee Break & Poster Session B P-031 to P-060

Hall A Aula Magna
08:55-09:00	Welcome back
09:00-10:30	Symposium 6 Toward a personalized treatment in mood disorders: Capturing the clinical and biological heterogeneity Chair: Francesco Benedetti, IRCSS Ospedale San Raffaele, Italy
	Improving healthcare of mood disorders with machine learning: The gene-environment, immunoinflammatory and neuroimaging signatures Benedetta Vai, IRCSS Ospedale San Raffaele, Italy
	Inflammatory biomarkers for an early screening of vulnerability and for a personalized intervention Annamaria Cattaneo, IIRRCCS Fatebenefratelli Brescia, Italy
	Identifying Depression Early in Adolescence (IDEA): From sociodemographic to biological risk Valeria Mondelli, King’s College London, UK
	Immunometabolic dysregulations in major depressive disorder: implications and examples for personalized treatment Femke Lamers, Amsterdam UMC, The Netherlands
10:30-11:15	Coffee Break & Poster Session C P-061 to P-090
11:15-12:00	Plenary Session 2 Risk and resilience in young people at risk for mood disorders Manon Hillegers, Erasmus University Rotterdam, The Netherlands
12:00-13:00	Industry Session 2
13:00-14:00	Lunch Break and Exhibition
14:00-14:45	Lifetime Achievement Award Plenary Lecture Sidney Kennedy, University of Toronto, Homewood Research Institute, Canada
14:45-16:15	Symposium 8 Anhedonia: From reward processing to therapeutic targets Chair: Sidney Kennedy, University of Toronto, Homewood Research Institute, Canada
	Anhedonia: From reward processing to therapeutic targets Sidney Kennedy, University of Toronto, Homewood Research Institute, Canada
	Overview of progress in brain mapping of reward processing Argyris Stringaris, University of London, UK
	Anhedonia in adolescence Ciara McCabe, University of Reading, UK
	Anhedonia: A transdiagnostic perspective with a focus on Substance Use Disorders Giacomo d'Andrea, University of Chieti-Pescara, Italy
16:15-17:00	Coffee Break & Poster Session D P-091 to P-0119
17:00-18:15	Symposium 10 Antiglutamatergic Therapy in Difficult to Treat Depression and Bipolar Disorder: Translational Application, Evidence and Mechanisms Chair: Mario Juruena, King's College London, UK
	Ketamine modulates reward-related areas: Studies in depression and treatment-resistant depression and bipola Mitul Mehta, King's College London, UK
	Ketamine in treatment resistant unipolar and bipolar depression and bipolar depression - which route is best? Mario Juruena, King's College London, UK
	The translational approach for antiglutamatergic therapy for mood disorders. Rodrigo Machado-Vieira, University of Texas, USA
18:15-18:30	Prize Giving & Closing Ceremony

Hall B Aula 111
08:55-09:00	Welcome back
09:00-10:30	Symposium 7 LITHIUM 3.0: From clinical to imaging perpectives, Chair: Marcella Bellani, University of Verona, Italy
	Lithium: New questions about the old element Allan Young, King’s College London, UK
	Is lithium neurotrophic? Josselin Houenou, CEA Saclay, France
	Lithium imaging: High and low – far and wide David Cousins, Newcastle University, UK
	Brain structural response to lithium in bipolar disorder Giuseppe Del Vecchio, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Italy
10:30-11:15	Coffee Break & Poster Session C P-061 to P-090
11:15-12:00
12:00-13:00
13:00-14:00	Lunch Break, Exhibition and Poster Viewing (Poster session B)
14:00-14:45
14:45-16:15	Symposium 9 Specificity vs NonSpecificity of the Mood Disorder Spectrum: Implications for Etiology and Treatment Chair: Martin Preisig, Lausanne University Hospital Center, Switzerland
	Specificity versus spectrum concepts of psychiatric diagnostic entities: Application of genetic epidemiologic approaches Kathleen R. Merikangas, National Institute of Mental Health, USA
	Evolution of psychopathology in offspring of parents with mood disorder subtypes Martin Preisig, Lausanne University Hospital Center, Switzerland
	Affective dynamics of the mood circumplex across development: Real time tracking of mood disorder subtypes Mathilde M. Husky, University of Bordeaux, France
	Affective dynamics of the mood circumplex across development: Real time tracking of mood disorder subtypes Jennifer Glaus, University of Bordeaux, France
16:15-17:00	Coffee Break & Poster Session D
17:00-18:15	Symposium 11 Embracing depression’s heterogeneity: aetiology, course and treatment for different depression dimensions Chair: Brenda Penninx, Amsterdam UMC, The Netherlands
	Immuno-Metabolic Depression: Bringing precision psychiatry from research to the clinics Yuri Milaneschi, Amsterdam UMC, The Netherlands
	The role of childhood trauma in characterizing depression Camille Souama, Amsterdam UMC, The Netherlands
	A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials Luca Sforzini, King's College London, UK
18:15-18:30	Prize Giving & Closing Ceremony

Hall C Sala Napoleonica
14:45-16:15	Residents Symposium: Bipolar Disorders: from stratification to new biomarkers and treatment Chairs: Paolo Brambilla (University of Milan, Italy) & Orsola Gambini (University of Milan, Italy, Italy) Discussant: Bernardo Dell'Osso, University of Milan, Italy
	SR-01 Assessing progression in Bipolar Disorder: From a ten-year observational study to a clinically- integrated staging model Monica Macellaro, University of Milan, Italy
	SR-02 Searching for suitable neuroimaging biomarkers in bipolar disorder Jair Soares, McGovern Medical School, USA
	RS-03 A multivariate approach to structural brain imaging signatures of bipolar disorder Drozdstoy Stoyanov, Medical University Plovdiv, Bulgaria
	SR-04 Unsupervised characterization of bipolar disorder based on regional brain morphology: findings from the StratiBip network Eleonora Maggioni, Politecnico di Milano, Italy
17:00-18:00	Lecture Moderator: Paolo Brambilla, University of Milan, Italy Strategies to get your research published in high impact journals Julio Licinio, State University of New York, USA

Home / Scientific Information » Scientific Programme

Newsletter Subscription